Evidence map›Paper›PMID 39396137›Full record

Trial reportMedicina oral, patologia oral y cirugia bucal2024

Evaluation of a new mouthwash formulated with Chlorhexidine and Cymenol after a scaling and root planing treatment in grade I and II periodontal patients.

P Hermida-Cabrera, F Aguilera, F Vivancos-Cuadras, L Ferrá-Domingo, D Torres-Lagares, J Gutiérrez-Pérez, T Pereira-Riveros, T Vinuesa, M-A Serrera-Figallo, M Baus-Domínguez

Abstract readEquivalence TrialRandomized Controlled Trial
In one paragraph

Trial report in Medicina oral, patologia oral y cirugia bucal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

P Hermida-CabreraDepartment of Stomatology Faculty of Dentistry, University of Seville 41009 Seville, Spain mbaus@us.es.
F Aguilera
F Vivancos-Cuadras
L Ferrá-Domingo
D Torres-Lagares
J Gutiérrez-Pérez
T Pereira-Riveros
T Vinuesa
M-A Serrera-Figallo
M Baus-Domínguez

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Periodontal disease is a multifactorial pathology whose treatment protocol is becoming increasingly standardized, relying, among others, on adjuvant therapies. This study aims to determine the efficacy of a new chlorhexidine compound compared with the gold standard 0.12% chlorhexidine during periodontal maintenance of a patient with periodontitis grade I or II after scaling and root planing treatment. Material and Methods: A parallel, randomized, double-blind clinical trial with two arms: (A) treatment with 0.12% chlorhexidine mouthwash; (B) treatment with new chlorhexidine mouthwash containing O-Cymen-5-Ol. The patient was examined: (D0) initial examination, (D7) clinical examination one week after treatment, (D14) clinical examination two weeks after treatment and (D28) clinical examination three weeks after treatment. They are collecting the following data: Plaque index (PI), gingival index (GI), bleeding index (BoP), pocket depth (PS), and attachment loss (CAL). Results: After a follow-up of 43 patients, no statistically significant differences were found between the groups at any of the times or for any of the parameters evaluated, meeting the predefined criteria of non-inferiority. Conclusions: The new chlorhexidine mouthwash proved to be non-inferior to 0.12% chlorhexidine in terms of efficacy during short-term periodontal maintenance after scaling and root planing.

Indexed as

ChlorhexidineMouthwashesPeriodontitisPhenolsCombined Modality TherapyDental Plaque IndexDental ScalingDouble-Blind MethodFemaleFollow-Up StudiesHumansMaleMiddle AgedPeriodontal Attachment LossPeriodontal IndexRoot PlaningChlorhexidineMouthwasheso-cymen-5-olPhenols

Identifiers

PMID39396137
PMCPMC11584970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.